Xingliang Feng

Xingliang Feng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2025 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
CHChaojuan Huang
Chaojuan Huang
HYHongtao You
Hongtao You
YZYuyang Zhang
Yuyang Zhang
LFLigang Fan
Ligang Fan
XFXingliang Feng
Xingliang Feng
NSNaiyuan Shao
Naiyuan Shao
Background: Stroke has emerged as an escalating public health challenge among middle-aged and older individuals in China, closely linked to glycolipid metabolic abnormalities. The Hemoglobin A1c/High-Density Lipoprotein Cholesterol (HbA1c/HDL-C) ratio, an integrated marker of glycolipid homeostasis, may serve as a novel predictor of stroke risk. Methods: Our investigation utilized data from the China Health and Retirement Longitudinal Study cohort (2011–2018). Stroke cases were identified based on self-reported, physician-confirmed diagnoses. Logistic regression models were established to determine the correlation between HbA1c/HDL-C and stroke prevalence (2011) as well as between cumulative mean HbA1c/HDL-C (2011–2015) and new stroke incidence (2015–2018). Additionally, smoothed curve fitting, subgroup analyses, and interaction tests were conducted to ensure the robustness of the findings. Results: In the cross-sectional analysis, 8,502 participants were enrolled, of whom 189 had a history of stroke. Our findings revealed a significant positive linear relationship between HbA1c/HDL-C and stroke prevalence after adjusting for covariates (OR: 1.26, 95% CI: 1.09–1.45). When HbA1c/HDL-C was categorized into tertiles, only the highest tertile (T3) showed a significant correlation with stroke prevalence compared to the lowest tertile (T1) (OR:1.71, 95% CI: 1.05–2.77). In the longitudinal analysis of 5,165 participants, 336 cases of new-onset stroke were identified over a follow-up period of 7 years. Adjusting for confounders, individuals with higher cumulative mean HbA1c/HDL-C exhibited an increased likelihood of new stroke incidence (OR: 1.14, 95% CI: 1.01–1.29). Using the T1 of cumulative mean HbA1c/HDL-C as a reference, the fully adjusted OR for stroke was 1.65 (95% CI: 1.21–2.24) in T2 and 1.54 (95% CI: 1.08–2.19) in T3. The predictive value of the HbA1c/HDL-C in stroke risk assessment have been significantly improved compared to the traditional HDL-C and HbA1c. Consistent associations were observed across most stratified subgroups. Conclusions: Elevated baseline and cumulative mean HbA1c/HDL-C levels are significantly associated with an increased risk of stroke among middle-aged and older individuals in China, underscoring the potential of HbA1c/HDL-C as a clinical marker for long-term stroke risk assessment and prevention strategies.

19 October 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
YZYuyang Zhang
Yuyang Zhang
YCYuxi Chen
Yuxi Chen
YMYangyang Mei
Yangyang Mei
RXRenfang Xu
Renfang Xu
HZHong Zhang
Hong Zhang
XFXingliang Feng
Xingliang Feng
Background: Several observational studies have reported the correlation between gut microbiota and the risk of erectile dysfunction (ED). However, the causal association between them remained unestablished owing to intrinsic limitations, confounding factors, and reverse causality. Therefore, the two-sample Mendelian randomization (MR) study was performed to determine the causal effect of gut microbiota on the risk of ED.Methods: The MR analysis utilized the publicly available genome-wide association study (GWAS) summary-level data to explore the causal associations between gut microbiota and ED. The gut microbiota data were extracted from the MiBioGen study (N = 18,340), and the ED data were extracted from the IEU Open GWAS (6,175 ED cases and 217,630 controls). The single nucleotide polymorphisms (SNPs) served as instrumental variables (IVs) by two thresholds of P-values, the first P-value setting as <1e-05 (locus-wide significance level) and the second P-value setting as <5e-08 (genome-wide significance level). The inverse variance weighted approach was used as the primary approach for MR analysis, supplemented with the other methods. In addition, sensitivity analyses were performed to evaluate the robustness of the MR results, including Cochran's Q test for heterogeneity, the MR-Egger intercept test for horizontal pleiotropy, the Mendelian randomization pleiotropy residual sum, and outlier (MR-PRESSO) global test for outliers, and the forest test and leave-one-out test for strong influence SNPs.Results: Our results presented that the increased abundance of Lachnospiraceae at family level (OR: 1.265, 95% CI: 1.054–1.519), Senegalimassilia (OR: 1.320, 95% CI: 1.064–1.638), Lachnospiraceae NC2004 group (OR: 1.197, 95% CI: 1.018–1.407), Tyzzerella3 (OR: 1.138, 95% CI: 1.017–1.273), and Oscillibacter (OR: 1.201, 95% CI: 1.035–1.393) at genus level may be risk factors for ED, while the increased abundance of Ruminococcaceae UCG013 (OR: 0.770, 95% CI: 0.615–0.965) at genus level may have a protective effect on ED. No heterogeneity or pleiotropy was found based on the previously described set of sensitivity analyses.Conclusion: Our MR analysis demonstrated that the gut microbiota had inducing and protective effects on the risk of ED. The results provide clinicians with novel insights into the treatment and prevention of ED in the future. Furthermore, our study also displays novel insights into the pathogenesis of microbiota-mediated ED.

6 January 2025 in Clinical and Translational Medicine
Verified
Journal Article
Open access
YZYuyang Zhang
Yuyang Zhang
MSMingqin Su
Mingqin Su
YCYiming Chen
Yiming Chen
LCLi Cui
Li Cui
WXWei Xia
Wei Xia
XFXingliang Feng
Xingliang Feng
Background: Chromosomal instability (CIN), a hallmark of cancer, is commonly linked to poor prognosis in high‐grade prostate cancer (PCa). Paradoxically, excessively high levels of CIN may impair cancer cell viability. Consequently, understanding how tumours adapt to CIN is critical for identifying novel therapeutic targets.Methods: Bioinformatic analyses were conducted to identify genes overexpressed in PCa tissues using The Cancer Genome Atlas (TCGA) and GEO datasets. Western blotting and immunohistochemistry assays were applied to determine the expression levels of euchromatic histone lysine methyltransferase 2 (EHMT2), pT232‐Aurora B and Cullin 3 (CUL3). The proliferation of cells was measured through CCK‐8 tests, clonogenesis and subcutaneous xenografts of human PCa cells in BALB/c nude mice. Live cell imaging, immunofluorescence (IF) and flow cytometry were used to confirm the role of EHMT2 in PCa cell mitosis. Co‐immunoprecipitation, Western blotting and IF assays further elucidated the underlying molecular mechanisms.Results: EHMT2 was highly expressed in metastatic PCa tissues exhibiting elevated CIN and was strongly associated with adverse clinical outcomes in patients with PCa. Silencing EHMT2 impaired cell division, inducing G2/M‐phase arrest and mitotic catastrophe in PCa cells. Mechanistically, EHMT2 is indispensable to ensure the full activation of Aurora B through centromeric R‐loop‐driven ATR–CHK1 pathway, with EHMT2 protein expression peaking during the G2/M‐phase. Moreover, CUL3 was identified as a binding partner of EHMT2, mediating its polyubiquitination and destabilising its protein levels.Conclusions: This study reveals a CUL3–EHMT2–Aurora B regulatory axis that safeguards accurate chromosome segregation in PCa cells, supporting the potential therapeutic application of EHMT2 inhibitors.Key points: Euchromatic histone lysine methyltransferase 2 (EHMT2) is overexpressed in advanced prostate cancer, restraining catastrophic chromosomal instability (CIN) and enhancing cell fitness. EHMT2 functions via the centromeric R‐loop‐driven ATR–CHK1–Aurora B pathway to promote chromosomal stability. EHMT2 confers enzalutamide resistance via activating Aurora B. Cullin 3 (CUL3) promotes EHMT2 destabilisation via deubiquitination.

14 August 2025 in BMC Endocrine Disorders
Verified
Journal Article
Open access
YMYangyang Mei
Yangyang Mei
BZBo Zhang
Bo Zhang
YCYiming Chen
Yiming Chen
RXRenfang Xu
Renfang Xu
DXdong xue
dong xue
XFXingliang Feng
Xingliang Feng
Testosterone is essential for male health, and its decline is closely associated with inflammation and lipid metabolism. The ratio of circulatory immune cells to high-density lipoprotein cholesterol (HDL-C) can comprehensively reflect these underlying pathophysiological mechanisms, including the neutrophil-to-HDL-C (NHR), platelet-to-HDL-C (PHR), monocyte-to-HDL-C (MHR), and lymphocyte-to-HDL-C (LHR). This study is the first to comprehensively assess the relationship between these ratios and male testosterone levels, as well as their ability to predict testosterone deficiency (TD). The study data were derived from the NHANES 2011–2016 cycles, including adult males who with data on the aforementioned indicators. Multivariable linear regression and logistic regression analyses were performed to assess the impact of these ratios on total testosterone levels and the risk of TD, respectively. Smoothed curve fitting was used to determine potential nonlinear relationships. Additionally, ROC analysis was conducted to compare the predictive ability of NHR, PHR, MHR, and LHR for TD. Finally, subgroup analysis was performed to confirm the stability of the results. A total of 6,079 participants were included in the study, with 1,680 participants having TD. In the fully adjusted models, log-transformed NHR, PHR, MHR, and LHR were all linearly negatively associated with total testosterone levels and linearly positively associated with the risk of TD. Specifically, for NHR, the corresponding beta and odds ratio (OR) were (β = -66.58, 95% CI: -78.08, -55.08, P < 0.0001) and (OR = 2.21, 95% CI: 1.76, 2.77, P < 0.0001), respectively. Similarly, for PHR, the OR for the risk of TD was 2.24 (95% CI: 1.64, 3.05, P < 0.0001), for MHR, the OR was 1.82 (95% CI: 1.42, 2.32, P < 0.0001), and for LHR, the OR was 2.11 (95% CI: 1.63, 2.74, P < 0.0001), indicating significant positive associations with TD risk. Additionally, ROC analysis indicated that NHR had the best predictive ability for TD among the ratios, with the highest AUC of 0.640 (95% CI: 0.625–0.655) and consistent results across subgroups. Our results suggest that log-transformed NHR, PHR, MHR, and LHR are positively associated with the risk of TD, with NHR being an effective predictor of TD. These findings highlight the potential of NHR to serve as an accessible supplementary biomarker for identifying men who may be at higher risk of TD, supporting early risk stratification and guiding further evaluation where appropriate. However, further prospective cohort studies are essential to validate our findings.

1 September 2024 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
YMYangyang Mei
Yangyang Mei
XWXiaogang Wang
Xiaogang Wang
YLYangmeina Li
Yangmeina Li
RXRenfang Xu
Renfang Xu
XFXingliang Feng
Xingliang Feng
Background: Liver transplantation (LT) has been recognized as the most effective therapy for end-stage liver disease (ESLD). However, the question of whether LT can improve erectile function in patients with ESLD remains controversial. Therefore, we conducted this meta-analysis to evaluate the association between LT and erectile dysfunction (ED). Methods: According to the PRISMA guidelines, studies were included after conducting searches in four databases from March 2024 onwards. These databases included PubMed, Cochrane Library, Web of Science, and Embase. The primary outcome of interest was to compare the International Index of Erectile Function (IIEF) scores between patients after and before LT. Standardized mean differences (SMDs) and their corresponding 95% confidence intervals (CIs) were utilized to assess the relationship between LT and ED. Results: The results showed that the LT group had higher IIEF-5 domain scores for erectile function compared to the control group (SMD =−0.31, 95% CI: −0.53 to −0.09), P=0.007). No heterogeneity or publication bias was detected in the results. Additionally, the IIEF-15 domain score was also found to be improved after LT. Specifically, the LT group had higher domain scores for erectile function (SMD =−0.77, 95% CI: −1.07 to −0.48, P<0.001), orgasmic function (SMD =−0.82, 95% CI: −1.12 to −0.52, P<0.001), sexual desire (SMD =−0.89, 95% CI: −1.19 to −0.59, P<0.001), intercourse satisfaction (SMD =−0.92, 95% CI: −1.22 to −0.62, P<0.001), and overall satisfaction (SMD =−0.87, 95% CI: −1.17 to −0.57, P<0.001). Conclusions: It is suggested by our meta-analysis that LT may contribute to improvements in erectile function among men with ESLD. This improvement may be related to the remarkable improvement in endocrine hormone disorders observed after LT. However, future studies with better designs and larger sample sizes are still needed to confirm our conclusions. Additionally, attention to erectile function before and after surgery in patients with liver failure is crucial.

5 January 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YMYangyang Mei
Yangyang Mei
YLYu Liu
Yu Liu
GZGuoyang Zhang
Guoyang Zhang
YCYiming Chen
Yiming Chen
WXWei Xia
Wei Xia
QZQianfeng Zhuang
Qianfeng Zhuang
Background: Erectile dysfunction (ED) is increasingly recognized as an early indicator of vascular health, with arteriogenic ED (AED) being the subtype most closely linked to endothelial dysfunction and atherosclerosis. Residual cholesterol (RC), a lipid fraction carried by triglyceride-rich lipoprotein remnants, has emerged as a novel marker of residual cardiovascular and metabolic risk. However, its relationship with ED, particularly AED, has not been well characterized. Methods: From April 2023 to May 2025, men presenting with ED and controls were consecutively recruited from three hospitals. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5), nocturnal penile tumescence and rigidity (NPTR), and color duplex Doppler ultrasonography (CDDU) to identify AED. Demographic, lifestyle, clinical, and biochemical data were collected. RC values were calculated using the formula: RC = total cholesterol (TC) – HDL-C – LDL-C. Logistic regression and ROC curve analyses were performed to evaluate the association and predictive value of lipid parameters for AED. Logistic regression analyses were performed to evaluate associations between lipid parameters and ED/AED, adjusting for potential confounders. Results: A total of 216 men with ED and 110 controls were included, among whom 118 were diagnosed with AED. RC levels were significantly higher in the ED group than in controls (0.57 ± 0.33 vs. 0.50 ± 0.18 mmol/L, P = 0.042), although the association with overall ED was attenuated in multivariable analysis (OR 1.086, 95% CI 0.997–1.182, P = 0.058). By contrast, RC remained robustly associated with AED after adjustment for age, BMI, smoking, CVD, TG, and TT (OR 1.471, 95% CI 1.275-1.697, P <0.001). In ROC analysis, RC showed the best predictive performance for AED (AUC 0.726, 95% CI 0.661–0.791), compared with TC (AUC 0.625, 95% CI 0.551–0.699) and TG (AUC 0.581, 95% CI 0.507–0.656). The optimal RC cutoff of 0.595 mmol/L yielded a sensitivity of 61.9% and specificity of 74.5%. Conclusions: RC was independently associated with AED and demonstrated stronger predictive ability than conventional lipid parameters. These findings suggest RC may serve as a useful biomarker for vascular risk stratification in men with ED, although prospective studies are warranted to validate these associations.